1 | Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer. | 22414467 |
2 | Reduced levels of p15INK4b, p16INK4a, p21cip1 and p27kip1 in pancreatic carcinoma. | 22293850 |
3 | Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. | 22173550 |
4 | Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro. | 21987623 |
5 | Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. | 21610144 |
6 | Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma. | 21572398 |
7 | Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. | 21269942 |
8 | SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma. | 20939879 |
9 | DNA methylation and histone H3-K9 modifications contribute to MUC17 expression. | 20926598 |
10 | Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. | 20173668 |
11 | Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. | 19893036 |
12 | Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs. | 19223499 |
13 | Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells. | 19035457 |
14 | DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease. | 18995218 |
15 | Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. | 18820670 |
16 | Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. | 18535405 |
17 | Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer. | 18528941 |
18 | Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases. | 18492726 |
19 | Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer. | 18475302 |
20 | MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells. | 18413738 |
21 | Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. | 18223216 |
22 | CpG island methylation profile of pancreatic intraepithelial neoplasia. | 18157091 |
23 | Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines. | 17895890 |
24 | Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. | 17675336 |
25 | DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. | 16537562 |
26 | Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines. | 16479257 |
27 | DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. | 16424060 |
28 | Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. | 16258509 |
29 | Alterations of tumor suppressor gene p16INK4a in pancreatic ductal carcinoma. | 15985168 |
30 | Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. | 15970691 |
31 | The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer. | 15662133 |
32 | Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. | 15383627 |
33 | Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer. | 15289340 |
34 | Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers. | 15121754 |
35 | The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. | 15073125 |
36 | Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia. | 14871978 |
37 | CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. | 14645499 |
38 | Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas. | 14614047 |
39 | Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. | 14501508 |
40 | Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. | 12874021 |
41 | Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. | 12865927 |
42 | Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. | 12839967 |
43 | O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. | 12684420 |
44 | Significance of thymidylate synthase activity in renal cell carcinoma. | 12684419 |
45 | Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. | 12684418 |
46 | Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. | 12673124 |
47 | Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. | 12651607 |
48 | Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors. | 12629131 |
49 | Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions. | 12610506 |
50 | Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. | 12591989 |